175 related articles for article (PubMed ID: 36357882)
1. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Combined Measurement of Serum Soluble IL-2R and Angiotensin-Converting Enzyme in the Detection of Uveitis Associated with Japanese Sarcoidosis.
Ishihara M; Meguro A; Ishido M; Takeuchi M; Shibuya E; Mizuki N
Clin Ophthalmol; 2020; 14():2311-2317. PubMed ID: 32848359
[TBL] [Abstract][Full Text] [Related]
4. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma.
Akpek EK; Maca SM; Christen WG; Foster CS
Ophthalmology; 1999 Dec; 106(12):2291-5. PubMed ID: 10599659
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of sIL-2R levels in B-cell lymphomas.
Yoshida N; Oda M; Kuroda Y; Katayama Y; Okikawa Y; Masunari T; Fujiwara M; Nishisaka T; Sasaki N; Sadahira Y; Mihara K; Asaoku H; Matsui H; Seto M; Kimura A; Arihiro K; Sakai A
PLoS One; 2013; 8(11):e78730. PubMed ID: 24236041
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Matrix Metalloproteinases in Eyes with Intraocular Lymphoma.
Fukutsu K; Kase S; Iwata D; Suzuki K; Namba K; Ishida S
Ocul Immunol Inflamm; 2022; 30(7-8):1798-1802. PubMed ID: 34379046
[TBL] [Abstract][Full Text] [Related]
7. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
8. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
[TBL] [Abstract][Full Text] [Related]
9. Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.
Chaput F; Amer R; Baglivo E; Touitou V; Kozyreff A; Bron D; Bodaghi B; LeHoang P; Bergstrom C; Grossniklaus HE; Chan CC; Pe'er J; Caspers LE
Ocul Immunol Inflamm; 2017 Oct; 25(5):639-648. PubMed ID: 27002464
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
Mitobe Y; Matsuda KI; Sonoda Y
Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
[TBL] [Abstract][Full Text] [Related]
11. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma.
Shimizu N; Nakao S; Hasunuma H; Nakaseko C; Shimizu T; Ebinuma H; Bujo H
Intern Med; 2024 Mar; ():. PubMed ID: 38432983
[TBL] [Abstract][Full Text] [Related]
13. Retrospective cytological study of intraocular lymphoma using vitreous and intraocular perfusion fluid.
Kinoshita Y; Takasu K; Adachi Y; Yuri T; Nagumo S; Shikata N
Diagn Cytopathol; 2012 Jul; 40(7):604-7. PubMed ID: 22707324
[TBL] [Abstract][Full Text] [Related]
14. Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma: in combination with the International Prognostic Index.
Goto H; Tsurumi H; Takemura M; Ino-Shimomura Y; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Goto N; Okuno M; Takami T; Seishima M; Moriwaki H
J Cancer Res Clin Oncol; 2005 Feb; 131(2):73-9. PubMed ID: 15503137
[TBL] [Abstract][Full Text] [Related]
15. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
Kitai R; Sasaki H; Matsuda K; Tsunetoshi K; Yamauchi T; Neishi H; Matsumura K; Tsunoda A; Takeuchi H; Sato K; Kikuta K
Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.
Prin L; Plumas J; Gruart V; Loiseau S; Aldebert D; Ameisen JC; Vermersch A; Fenaux P; Bletry O; Capron M
Blood; 1991 Nov; 78(10):2626-32. PubMed ID: 1726707
[TBL] [Abstract][Full Text] [Related]
17. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
[TBL] [Abstract][Full Text] [Related]
18. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
Chang CS; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
Li C; Li W; Xu G; You M; Wu W; Kuang L
Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
